Neohydro Technologies Corp.

CIK:0001428816|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Revenue	$ 52,435	$ 18,252	$ 119,947	$ 79,356
Operating Expenses
Amortization			7,695
Software research and development	8,864	4,546	30,464	10,946
General and administrative expenses	60,728	53,785	186,552	179,942
Total operating expenses	69,592	58,331	224,711	190,888
Loss from operations	(17,157)	(40,079)	(104,764)	(111,532)
Other Income (Expenses):
Gain (loss) on change in fair value of derivative liabilities	169,309	(180,134)	254,537	(682,331)
Interest expense	(37,830)	(14,335)	(76,236)	(110,797)
Total other income (expenses)	131,479	(194,469)	178,301	(793,128)
Income (loss) before taxes	114,322	(234,548)	73,537	(904,660)
Income tax (expense) benefit
Net income (loss)	$ 114,322	$ (234,548)	$ 73,537	$ (904,660)
Net income (loss) per share
- basic	$ 0.33	$ (0.73)	$ 0.21	$ (3.25)
- diluted	$ 0.00	$ (0.73)	$ 0.00	$ (3.25)
Weighted average shares outstanding
- basic	349,399	320,608	342,731	278,134
- diluted	64,173,746	320,608	64,167,078	278,134

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from Operating Activities
Net income (loss)	$ 73,537	$ (904,660)
Adjustments to reconcile net loss to net cash used in operations:
Amortization	7,695
Accrued interest converted to shares		5,704
Transfer agent fees issued by shares		7,804
(Gain) loss on change in fair value of derivative liabilities	(254,537)	682,331
Amortization of discounts on convertible notes	45,500	81,855
Amortization of deferred financing costs	2,066	6,605
Interest expense due to default on convertible note	3,780	3,680
Imputed interest	525	525
Changes in operating assets and liabilities:
Accounts receivable	2,750	(3,000)
Prepaid expenses	970
Deferred revenue		(29,000)
Accounts payable and accrued expenses	42,717	60,282
Accounts payable and accrued expenses, related party	27,635	34,922
Net cash used in operating activities	(47,362)	(52,952)
Cash flows from Financing Activities
Proceeds from convertible notes	30,000	56,500
Proceeds from sale of Series A Preferred Shares	25,000
Net cash provided by financing activities	55,000	56,500
Net increase (decrease) in cash during the period	7,638	3,548
Cash, beginning of period	5,440	2,662
Cash, end of period	13,078	6,210
Cash paid for:
Interest
Income taxes
Supplemental non-cash investing and financing activities:
Debt principal converted to shares	4,680	91,300
Accrued interest converted to shares	1,079	9,224
Derivative liability reclassified as additional paid-in capital	28,790	475,922
Derivative liability - debt discount		49,680
Debt issuance financing cost		$ 4,500

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current
Cash	$ 13,078	$ 5,440
Accounts receivable		2,750
Prepaid expenses		970
Total Current Assets	13,078	9,160
Trademark and Patent		7,695
Total Assets	13,078	16,855
Current
Accounts payable and accrued liabilities	293,720	252,082
Accounts payable and accrued liabilities - related parties	115,928	88,293
Loans payable	17,000	17,000
Loan payable - related party	12,000	12,000
Derivative liabilities	248,441	497,988
Convertible notes, net of unamortized discounts and deferred financing cost	236,030	193,144
Other liabilities	72,400	72,400
Total Current Liabilities	995,519	1,132,907
Total Liabilities	995,519	1,132,907
STOCKHOLDERS' DEFICIT
Common Stock, $0.00001 par value; authorized: 4,450,000,000 shares, 349,399 and 320,608 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	3	3
Additional paid-in capital	3,903,127	3,843,055
Accumulated deficit	(4,885,834)	(4,959,371)
Total Stockholders' Deficit	(982,441)	(1,116,052)
Total Liabilities and Stockholders' Deficit	13,078	16,855
Series A Preferred shares
STOCKHOLDERS' DEFICIT
Preferred Stock	253	251
Series B Preferred shares
STOCKHOLDERS' DEFICIT
Preferred Stock	$ 10	$ 10